Agile, Data-Driven Life Cycle Management for Continuous Manufacturing
ISPE
JULY 6, 2023
billion US in 2021 to $1.9 1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. In 2021, CONTINUUS Pharmaceuticals secured a$69.3 This is demonstrated by the rise from $1.05
Let's personalize your content